DIO WHITENING

Manufacturer: Dio Corporation | KMPharmaceutical Co., Ltd.
Effective date: 2017-06-01
Label type: HUMAN OTC DRUG LABEL
Version: 2
Source: full-release
Hydrated at: 2026-05-31 22:50:02

Label at a glance#

ProductDIO WHITENING

Active ingredientSILICON DIOXIDE, .ALPHA.-TOCOPHEROL ACETATE, HYDROGEN PEROXIDE

Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

colloidal silicon dioxide, tocopherol acetate, 35% hydrogen peroxide solution

INACTIVE INGREDIENT SECTION

xylityl, sorbitol solution 70%, polyethylene glycol 1500, carboxymethylcellulose sodium, xanthan gum, poly vinyl pirrolidone, sodium stannate, etc.

OTC - PURPOSE SECTION

for dental care

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

keep out of reach of the children

INDICATIONS & USAGE SECTION

brush teeth with your toothbrush

WARNINGS SECTION

store at room temperature

DOSAGE & ADMINISTRATION SECTION

for dental use only

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
5eb9f24b-9328-475e-af0a-18021935eb6a	Product name	1	20180220

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
75902-4001-1	2020-01-31	C162847	48780-1	9d75b9d0-2983-f424-e053-dadaa90a57ce	Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
75902-4001-1	DIO WHITENING	90 g in 1 BOTTLE, PUMP	PASTE, DENTIFRICE	90		2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
75902-4001	DIO WHITENING (SODIUM FLUORIDE) PASTE, DENTIFRICE [DIO CORPORATION]	2	Legacy NDC, 1 package rows	20170605_1b5a5f59-fa6a-4ce6-a360-502fb651eb1a.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
.ALPHA.-TOCOPHEROL ACETATE	ACTIVE INGREDIENT	9E8X80D2L0	1
HYDROGEN PEROXIDE	ACTIVE INGREDIENT	BBX060AN9V	1
SILICON DIOXIDE	ACTIVE INGREDIENT	ETJ7Z6XBU4	1
.ALPHA.-TOCOPHEROL	ACTIVE MOIETY	H4N855PNZ1	1
HYDROGEN PEROXIDE	ACTIVE MOIETY	BBX060AN9V	1
SILICON DIOXIDE	ACTIVE MOIETY	ETJ7Z6XBU4	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	1
XYLITOL	INACTIVE INGREDIENT	VCQ006KQ1E	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

DIO WHITENING
Sodium fluoride
XYLITOL
WATER
SILICON DIOXIDE
.ALPHA.-TOCOPHEROL ACETATE
.ALPHA.-TOCOPHEROL
HYDROGEN PEROXIDE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
75902-4001	75902-4001-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
XYLITOL	VCQ006KQ1E	IACT
WATER	059QF0KO0R	IACT
SILICON DIOXIDE	ETJ7Z6XBU4	ACTIB
.ALPHA.-TOCOPHEROL ACETATE	9E8X80D2L0	ACTIM
HYDROGEN PEROXIDE	BBX060AN9V	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 12 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
XYLITOL	XYLITOL	VCQ006KQ1E	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		72 mg	Exact identifier — unii candidate 12 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	PASTE / ORAL		180 mg	Exact identifier — unii candidate 12 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	SUSPENSION / ORAL		1500 mg	Exact identifier — unii candidate 12 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	TABLET / ORAL	15.04 mg		Exact identifier — unii candidate 12 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	TABLET, ORALLY DISINTEGRATING / ORAL		360 mg	Exact identifier — unii candidate 12 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	SOLUTION / ORAL		21600 mg	Exact identifier — unii candidate 12 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	FILM, SOLUBLE / ORAL		29 mg	Exact identifier — unii candidate 12 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	SUSPENSION, EXTENDED RELEASE / ORAL		9000 mg	Exact identifier — unii candidate 12 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	POWDER, FOR SUSPENSION / ORAL	4223 mg		Exact identifier — unii candidate 12 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	SPRAY / SUBLINGUAL		22 mg	Exact identifier — unii candidate 12 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	GUM, CHEWING / BUCCAL		11915 mg	Exact identifier — unii candidate 12 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	TABLET, EXTENDED RELEASE / ORAL		2752 mg	Exact identifier — unii candidate 12 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
50e23c08-7305-6d1a-e054-00144ff8d46c			1b5a5f59-fa6a-4ce6-a360-502fb651eb1a	2017-06-01	Warnings	Exact identifier spl id: 50e23c08-7305-6d1a-e054-00144ff8d46c spl set id: 1b5a5f59-fa6a-4ce6-a360-502fb651eb1a

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.